Changes in antidepressant metabolism and dosing across pregnancy and early postpartum.

The Journal of Clinical Psychiatry
Dorothy K SitKatherine L Wisner

Abstract

Little information about the disposition of individual antidepressant drugs during pregnancy has been published. We examined the dose requirements and level-to-dose (L/D) ratios of citalopram, escitalopram, and sertraline during pregnancy and after birth. Women aged from 32 to 43 years with major depressive disorder according to the Structured Clinical Interview for DSM-IV Axis I Disorders participated in the study. Doses were charted across each week of gestation and post-partum. Samples were collected at 20, 30, and 36 weeks' gestation; delivery; and at 2 and 12 weeks postpartum. Plasma trough levels were obtained 8 to 15 hours after dose intake. Across pregnancy and postpartum, the mean dose-corrected plasma concentrations (L/D ratios) of S- and R-citalopram and S-sertraline, and the corresponding primary chiral metabolites S- and R-desmethylcitalopram and N-desmethylsertra-line were assessed. The samples were analyzed for concentrations of stereospecific parent drug and metabolites. The study was conducted from 2003 to 2006. Three women received citalopram, 2 women were treated with escitalopram, and 6 women received sertraline. In 4 of 5 subjects who received citalopram or escitalopram and 5 of 6 subjects who received sert...Continue Reading

References

Apr 1, 1979·The British Journal of Psychiatry : the Journal of Mental Science·S A Montgomery, M Asberg
Jan 1, 1992·Journal of Neural Transmission. General Section·J HyttelC Sánchez
Dec 1, 1991·International Clinical Psychopharmacology·S J Warrington
Jan 1, 1982·Progress in Neuro-psychopharmacology & Biological Psychiatry·J Hyttel
Nov 14, 1997·Clinical Pharmacology and Therapeutics·M WadeliusA Rane
Dec 3, 1999·Journal of Clinical Pharmacy and Therapeutics·E Tanaka
May 17, 2000·Depression and Anxiety·A HostetterA Llewellyn
Jul 27, 2000·Obstetrics and Gynecology·B B Little
Mar 13, 2002·Public Health Reports·P W YoonL D Edmonds
Aug 9, 2002·Journal of Affective Disorders·Marjorie BeeghlyEdward Z Tronick
Aug 22, 2002·Clinical Pharmacology and Therapeutics·Tuija HeikkinenKari Laine
Sep 12, 2002·Clinical Pharmacokinetics·Zeruesenay DestaDavid A Flockhart
Mar 27, 2003·Therapeutic Drug Monitoring·Margareta ReisFinn Bengtsson
Sep 5, 2003·European Journal of Clinical Pharmacology·R McGreadyF Nosten
Sep 13, 2003·British Journal of Clinical Pharmacology·Karin HerrlinLeif Bertilsson
Sep 17, 2003·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Bang-Ning YuHong-Hao Zhou
Feb 1, 1960·Journal of Neurology, Neurosurgery, and Psychiatry·M HAMILTON
Nov 18, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Ulrich M ZangerMichel Eichelbaum
Jul 17, 2004·British Journal of Clinical Pharmacology·Bruce Green, Stephen B Duffull
Dec 14, 2004·Clinical Pharmacology and Therapeutics·Rolf P G van HeeswijkD William Cameron
Feb 8, 2005·American Journal of Obstetrics and Gynecology·Timothy S TracyUNKNOWN National Institute for Child Health and Human Development Network of Maternal-Fetal-Medicine Units
Feb 11, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Mostafa El MansariNasser Haddjeri
Mar 30, 2005·Expert Opinion on Drug Safety·Sanjog KalraAdrienne Einarson
Sep 24, 2005·Clinical Pharmacokinetics·Gail D Anderson
Feb 2, 2006·The International Journal of Neuropsychopharmacology·Mostafa El MansariNasser Haddjeri
Jul 21, 2006·Journal of Clinical Psychopharmacology·Katherine L WisnerEydie L Moses-Kolko
Oct 20, 2006·Clinical Pharmacokinetics·Svein I Johannessen, Torbjörn Tomson

❮ Previous
Next ❯

Citations

Jul 16, 2010·Journal of Clinical Psychopharmacology·Dorothy SitKatherine L Wisner
Sep 8, 2009·Current Opinion in Psychiatry·Anna R BrandonJohn Z Sadler
Feb 23, 2011·International Journal of Women's Health·Elizabeth FitelsonKristin Leight
Sep 12, 2009·Clinical Pharmacokinetics·F F Tessa VerversAlfred F A M Schobben
Aug 10, 2011·The Journal of Clinical Psychiatry·Dorothy SitKatherine L Wisner
Nov 7, 2013·Pharmacogenomics·Anders Helldén, Parvaz Madadi
Mar 29, 2014·Archives of Women's Mental Health·Lauren M OsborneKatherine L Wisner
Jul 6, 2010·Women's Health·Christopher TjoaDeborah R Kim
Jun 6, 2015·The Journal of Maternal-fetal & Neonatal Medicine : the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians·Faruk Uguz
Oct 12, 2012·Asian Journal of Psychiatry·Koumudi GodboleSanjay Phadke
Jul 6, 2010·Pharmacology, Biochemistry, and Behavior·R M CraftK T Tsutsui
May 11, 2010·Neurochemistry International·Liang PengMeixia Zhang
Apr 14, 2010·The Psychiatric Clinics of North America·Lee S CohenMarlene P Freeman
Jan 12, 2010·Forensic Science International : Synergy·Lisa O'BrienGideon Koren
Oct 24, 2009·Physiology & Behavior·Brittany M NavarreRebecca M Craft
Jun 6, 2009·Journal of Psychosocial Nursing and Mental Health Services·Robert H Howland
May 23, 2012·British Journal of Clinical Pharmacology·Simon H L Thomas, Laura M Yates
Dec 18, 2012·Acta Psychiatrica Scandinavica·N ByattM P Freeman
Aug 10, 2010·Depression and Anxiety·Katherine L Wisner
Sep 8, 2015·Acta Psychiatrica Scandinavica·E R LarsenUNKNOWN Danish Society of Clinical Pharmacology
Apr 30, 2014·Expert Opinion on Pharmacotherapy·Deborah R KimKatherine L Wisner
Sep 4, 2015·Indian Journal of Psychiatry·Shashi RaiIndira Sharma
Nov 12, 2013·Best Practice & Research. Clinical Obstetrics & Gynaecology·Shona Ray, Zachary N Stowe
Mar 22, 2014·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Muaed Jamal Alomar
Jun 11, 2016·Journal of Affective Disorders·Sheehan D FisherStephen Wisniewski
Jul 12, 2014·Thérapie·Alice PanchaudNicolas Widmer
Jul 20, 2016·American Journal of Obstetrics and Gynecology·Leah C SusserAlison D Hermann
Nov 2, 2016·PLoS Medicine·Gali ParienteGideon Koren
Apr 2, 2014·Therapeutic Advances in Psychopharmacology·Judith BosmanWobbe Hospes
Mar 22, 2018·Clinical Obstetrics and Gynecology·Shari I LusskinElizabeth S Albertini
Dec 14, 2017·Pediatrics International : Official Journal of the Japan Pediatric Society·Sinchul JwaYutaka Sumida
Nov 18, 2008·Journal of Clinical Psychopharmacology·Marlene P FreemanFrancisco Moreno
Feb 26, 2014·Pharmacological Reviews·Chase H BourkeMichael J Owens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.